BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 26373560)

  • 1. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
    Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
    Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
    Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal Influence on the Risk of Relapse at a Rise of Antineutrophil Cytoplasmic Antibodies in Vasculitis Patients with Renal Involvement.
    Kemna MJ; Cohen Tervaert JW; Broen K; Timmermans SAMEG; van Paassen P; Damoiseaux JGMC
    J Rheumatol; 2017 Apr; 44(4):473-481. PubMed ID: 28202741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.
    Tanaka H; Yamaguchi M; Katsuno T; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Banno S; Ishimoto T; Ito Y
    PLoS One; 2020; 15(12):e0243572. PubMed ID: 33301468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
    Terrier B; Pagnoux C; Perrodeau É; Karras A; Khouatra C; Aumaître O; Cohen P; Decaux O; Desmurs-Clavel H; Maurier F; Gobert P; Quémeneur T; Blanchard-Delaunay C; Bonnotte B; Carron PL; Daugas E; Ducret M; Godmer P; Hamidou M; Lidove O; Limal N; Puéchal X; Mouthon L; Ravaud P; Guillevin L;
    Ann Rheum Dis; 2018 Aug; 77(8):1150-1156. PubMed ID: 29724729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
    Lurati-Ruiz F; Spertini F
    J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
    Kim DS; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.
    Fussner LA; Hummel AM; Schroeder DR; Silva F; Cartin-Ceba R; Snyder MR; Hoffman GS; Kallenberg CG; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; William St Clair E; Tchao NK; Stone JH; Specks U;
    Arthritis Rheumatol; 2016 Jul; 68(7):1700-10. PubMed ID: 26882078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
    Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears AK; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
    Ann Intern Med; 2007 Nov; 147(9):611-9. PubMed ID: 17975183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients.
    Hasegawa M; Hattori K; Sugiyama S; Asada H; Yamashita H; Takahashi K; Hayashi H; Koide S; Sato W; Yuzawa Y
    Mod Rheumatol; 2016; 26(1):110-4. PubMed ID: 25967129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
    Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
    Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease.
    Cao Y; Tian Z; Li W; Ma L; Yu Y; Ren W
    J Rheumatol; 2014 May; 41(5):916-22. PubMed ID: 24634200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
    Hogan SL; Falk RJ; Chin H; Cai J; Jennette CE; Jennette JC; Nachman PH
    Ann Intern Med; 2005 Nov; 143(9):621-31. PubMed ID: 16263884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.
    Lee SW; Yu MY; Baek SH; Ahn SY; Kim S; Na KY; Chae DW; Chin HJ
    J Korean Med Sci; 2016 Apr; 31(4):542-6. PubMed ID: 27051237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.